Pittenger & Anderson Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,796 shares of the healthcare conglomerate’s stock after purchasing an additional 246 shares during the period. Pittenger & Anderson Inc.’s holdings in UnitedHealth Group were worth $5,339,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of UNH. Patriot Financial Group Insurance Agency LLC grew its holdings in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after acquiring an additional 603 shares during the period. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the second quarter worth $110,000. Kings Point Capital Management grew its holdings in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after acquiring an additional 150 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its holdings in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth $121,000. 86.00% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Shares Bought by Pittenger & Anderson Inc.” was originally reported by Stock Observer and is the property of of Stock Observer. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.thestockobserver.com/2017/11/15/unitedhealth-group-incorporated-unh-shares-bought-by-pittenger-anderson-inc.html.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at $211.71 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The company has a market capitalization of $204,541.08, a PE ratio of 21.99, a P/E/G ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 52-week low of $148.56 and a 52-week high of $213.93.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $2.17 earnings per share. analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is currently 33.26%.
Several brokerages recently commented on UNH. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $212.00 price objective on shares of UnitedHealth Group in a report on Thursday, July 20th. Citigroup Inc. lifted their price objective on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $210.00 price objective (up previously from $190.00) on shares of UnitedHealth Group in a report on Saturday, July 22nd. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price objective (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Finally, Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a report on Tuesday, August 1st. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $216.65.
In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the sale, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold 72,149 shares of company stock worth $14,212,342 over the last three months. 0.89% of the stock is currently owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.